{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:50:08Z","timestamp":1775620208832,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11686-021-00445-w","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T11:02:55Z","timestamp":1624705375000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synthesis of Tellurium Oxide (TeO2) Nanorods and Nanoflakes and Evaluation of Its Efficacy Against Leishmania major In Vitro and In Vivo"],"prefix":"10.1007","volume":"67","author":[{"given":"Pooya","family":"Tavakoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-8214","authenticated-orcid":false,"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Delavari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"KarimiPourSaryazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Saaid","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salimeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"issue":"1","key":"445_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1039\/c5cs00674k","volume":"45","author":"V Gutierrez","year":"2016","unstructured":"Gutierrez V, Seabra AB, Reguera RM, Khandare J, Calder\u00f3n M (2016) New approaches from nanomedicine for treating leishmaniasis. Chem Soc Rev 45(1):152\u2013168. https:\/\/doi.org\/10.1039\/c5cs00674k","journal-title":"Chem Soc Rev"},{"issue":"22","key":"445_CR2","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/cr500365f","volume":"114","author":"AS Nagle","year":"2014","unstructured":"Nagle AS, Khare S, Kumar AB, Supek F, Buchynskyy A, Mathison CJ, Chennamanen NK, Pendem N, Buckner FS, Gelb MH, Molteni V (2014) Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev 114(22):11305\u201311347. https:\/\/doi.org\/10.1021\/cr500365f","journal-title":"Chem Rev"},{"issue":"5","key":"445_CR3","doi-asserted-by":"publisher","first-page":"35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer M (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7(5):35671. https:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PLoS ONE"},{"issue":"10","key":"445_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apjtm","volume":"9","author":"A Oryan","year":"2016","unstructured":"Oryan A, Akbari M (2016) Worldwide risk factors in leishmaniasis. Asian Pac J Trop 9(10):925\u2013932. https:\/\/doi.org\/10.1016\/j.apjtm","journal-title":"Asian Pac J Trop"},{"key":"445_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jgar","volume":"14","author":"A Shokri","year":"2018","unstructured":"Shokri A, Abastabar M, Keighobadi M, Emami S, Fakhar M, Teshnizi SH, Makimura K, Rezaei-Matehkolaei A, Mirzaei H (2018) Promising antileishmanial activity of novel imidazole antifungal drug Luliconazole against Leishmania major: in vitro and in silico studies. J Glob Antimicrob Resist 14:260\u2013265. https:\/\/doi.org\/10.1016\/j.jgar","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"445_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1021\/pr5008202","volume":"14","author":"SD Lamour","year":"2014","unstructured":"Lamour SD, Veselkov KA, Posma JM, Giraud E, Rogers ME, Croft S, Marchesi JR, Holmes E, Seifert K, Saric J (2014) Metabolic, immune, and gut microbial signals mount a systems response to Leishmania major infection. J Proteome Res 14(1):318\u2013329. https:\/\/doi.org\/10.1021\/pr5008202","journal-title":"J Proteome Res"},{"issue":"3","key":"445_CR7","first-page":"399","volume":"123","author":"SL Croft","year":"2006","unstructured":"Croft SL, Seifert K, Yardley V (2006) Current scenario of drug development for leishmaniasis. Indian J Med Res 123(3):399\u2013410","journal-title":"Indian J Med Res"},{"issue":"4","key":"445_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S Sundar","year":"2000","unstructured":"Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31(4):1104\u20131107. https:\/\/doi.org\/10.1086\/318121","journal-title":"Clin Infect Dis"},{"key":"445_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","volume":"172","author":"M Akbari","year":"2017","unstructured":"Akbari M, Oryan A, Hatam G (2017) Application of nanotechnology in treatment of leishmaniasis: a review. Acta Trop 172:86\u201390. https:\/\/doi.org\/10.1016\/j.actatropica.2017.04.029","journal-title":"Acta Trop"},{"key":"445_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.amsu.2017.07.057","volume":"21","author":"M Soosaraei","year":"2017","unstructured":"Soosaraei M, Fakhar M, Teshnizi SH, Hezarjaribi HZ, Banimostafavi ES (2017) Medicinal plants with promising antileishmanial activity in Iran: a systematic review and meta-analysis. Ann Med Surg 21:63\u201380. https:\/\/doi.org\/10.1016\/j.amsu.2017.07.057","journal-title":"Ann Med Surg"},{"issue":"8","key":"445_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/bem.21945","volume":"36","author":"E Dolat","year":"2015","unstructured":"Dolat E, Rajabi O, Salarabadi SS, Yadegari-Dehkordi S, Sazgarnia A (2015) Silver nanoparticles and electroporation: their combinational effect on leishmania major. Bioelectromagnetics 36(8):586\u2013596. https:\/\/doi.org\/10.1002\/bem.21945","journal-title":"Bioelectromagnetics"},{"issue":"6","key":"445_CR12","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.tiv.2013.06.002","volume":"27","author":"A Jebali","year":"2013","unstructured":"Jebali A, Kazemi B (2013) Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis. Toxicol In Vitro 27(6):1896\u20131904. https:\/\/doi.org\/10.1016\/j.tiv.2013.06.002","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"445_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jtemb.2012.11.002","volume":"27","author":"N Beheshti","year":"2013","unstructured":"Beheshti N, Soflaei S, Shakibaie M, Yazdi MH, Ghaffarifar F, Dalimi A, Shahverdi AR (2013) Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies. J Trace Elem Med Biol 27(3):203\u2013207. https:\/\/doi.org\/10.1016\/j.jtemb.2012.11.002","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"445_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1590\/s0001-37652009000300006","volume":"81","author":"RL Cunha","year":"2009","unstructured":"Cunha RL, Gouvea IE, Juliano L (2009) A glimpse on biological activities of tellurium compounds. An Acad Bras Cienc 81(3):393\u2013407. https:\/\/doi.org\/10.1590\/s0001-37652009000300006","journal-title":"An Acad Bras Cienc"},{"issue":"20","key":"445_CR15","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1021\/ja401360a","volume":"135","author":"F Yu","year":"2013","unstructured":"Yu F, Li P, Wang B, Han K (2013) Reversible near-infrared fluorescent probe introducing tellurium to mimetic glutathione peroxidase for monitoring the redox cycles between peroxynitrite and glutathione in vivo. J Am Chem Soc 135(20):7674\u20137680. https:\/\/doi.org\/10.1021\/ja401360a","journal-title":"J Am Chem Soc"},{"issue":"13","key":"445_CR16","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1016\/j.bmc.2014.04.063","volume":"22","author":"V Lutz","year":"2014","unstructured":"Lutz V, Mannchen F, Krebs M, Park N, Kr\u00fcger C, Raja A, Sasse F, Baro A, Laschat S (2014) SAR studies on hydropentalene derivatives\u2014important core units of biologically active tetramic acid macrolactams and ptychanolides. Bioorg Med Chem 22(13):3252\u20133261. https:\/\/doi.org\/10.1016\/j.bmc.2014.04.063","journal-title":"Bioorg Med Chem"},{"issue":"101","key":"445_CR17","doi-asserted-by":"publisher","first-page":"98829","DOI":"10.1039\/C6RA15880C","volume":"6","author":"J Zakrzewski","year":"2016","unstructured":"Zakrzewski J, Huras B, Kie\u0142czewska A, Krawczyk M (2016) Reactions of nitroxides 16. First nitroxides containing tellurium atom. RSC Adv 6(101):98829\u201398834. https:\/\/doi.org\/10.1039\/C6RA15880C","journal-title":"RSC Adv"},{"issue":"2","key":"445_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00001813-200302000-00009","volume":"14","author":"L Engman","year":"2003","unstructured":"Engman L, Al-Maharik N, McNaughton M, Birmingham A, Powis G (2003) Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants. Anticancer Drugs 14(2):153\u2013161. https:\/\/doi.org\/10.1097\/00001813-200302000-00009","journal-title":"Anticancer Drugs"},{"issue":"51","key":"445_CR19","doi-asserted-by":"publisher","first-page":"10577","DOI":"10.1002\/chem.201000884","volume":"68","author":"M Doering","year":"2012","unstructured":"Doering M, Diesel B, Gruhlke MC, Viswanathan UM, M\u00e1nikov\u00e1 D, Chovanec M, Burkholz T, Slusarenko AJ, Kiemer AK, Jacob C (2012) Selenium-and tellurium-containing redox modulators with distinct activity against macrophages: possible implications for the treatment of inflammatory diseases. Tetrahedron 68(51):10577\u201310585. https:\/\/doi.org\/10.1002\/chem.201000884","journal-title":"Tetrahedron"},{"key":"445_CR20","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00060","author":"PT Bandeira","year":"2019","unstructured":"Bandeira PT, JoPA S, DbB S, Garcia FP, Nakamura CV, de Oliveira AR, Piovan L (2019) Diacetal ditellurides as highly active and selective antiparasitic agents toward Leishmania amazonensis. ACS Med Chem Lett. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00060","journal-title":"ACS Med Chem Lett"},{"issue":"8","key":"445_CR21","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","volume":"45","author":"HW Murray","year":"2001","unstructured":"Murray HW (2001) Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 45(8):2185\u20132197. https:\/\/doi.org\/10.1128\/AAC.45.8.2185-2197.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"445_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1874104501105010031","volume":"5","author":"K Seifert","year":"2011","unstructured":"Seifert K (2011) Structures, targets and recent approaches in anti-leishmanial drug discovery and development. Open J Med Chem 5:31. https:\/\/doi.org\/10.2174\/1874104501105010031","journal-title":"Open J Med Chem"},{"issue":"12","key":"445_CR23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.phymed.2011.03.004","volume":"18","author":"R Sen","year":"2011","unstructured":"Sen R, Chatterjee M (2011) Plant derived therapeutics for the treatment of Leishmaniasis. Phytomedicine 18(12):1056\u20131069. https:\/\/doi.org\/10.1016\/j.phymed.2011.03.004","journal-title":"Phytomedicine"},{"issue":"06","key":"445_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1055\/s-0030-1250663","volume":"77","author":"AG Tempone","year":"2011","unstructured":"Tempone AG, de Oliveira CM, Berlinck RG (2011) Current approaches to discover marine antileishmanial natural products. Planta Med 77(06):572\u2013585. https:\/\/doi.org\/10.1055\/s-0030-1250663","journal-title":"Planta Med"},{"issue":"8","key":"445_CR25","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","volume":"15","author":"TS Tiuman","year":"2011","unstructured":"Tiuman TS, Santos AO, Ueda-Nakamura T, Dias Filho BP, Nakamura CV (2011) Recent advances in leishmaniasis treatment. Int J Infect Dis 15(8):e525\u2013e532. https:\/\/doi.org\/10.1016\/j.ijid.2011.03.021","journal-title":"Int J Infect Dis"},{"key":"445_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ultsonch.2018.01.022","volume":"43","author":"R Abazari","year":"2018","unstructured":"Abazari R, Mahjoub AR, Molaie S, Ghaffarifar F, Ghasemi E, Slawin AM, Carpenter-Warren C (2018) The effect of different parameters under ultrasound irradiation for synthesis of new nanostructured Fe3O4@ bio-MOF as an efficient anti-leishmanial in vitro and in vivo conditions. Ultrason Sonochem 43:248\u2013261. https:\/\/doi.org\/10.1016\/j.ultsonch.2018.01.022","journal-title":"Ultrason Sonochem"},{"key":"445_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2019.08.003","author":"P Tavakoli","year":"2019","unstructured":"Tavakoli P, Ghaffarifar F, Delavari H, Shahpari N (2019) Efficacy of manganese oxide (Mn2O3) nanoparticles against Leishmania major in vitro and in vivo. J Trace Elem Med Biol. https:\/\/doi.org\/10.1016\/j.jtemb.2019.08.003","journal-title":"J Trace Elem Med Biol"},{"key":"445_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.02.008","author":"S Khademvatan","year":"2019","unstructured":"Khademvatan S, Eskandari K, Hazrati-Tappeh K, Rahim F, Foroutan M, Yousefi E, Asadi N (2019) In silico and in vitro comparative activity of green tea components against Leishmania infantum. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/j.jgar.2019.02.008","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"445_CR29","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1021\/cr0406559","volume":"104","author":"CW Nogueira","year":"2004","unstructured":"Nogueira CW, Zeni G, Rocha JB (2004) Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104(12):6255\u20136286. https:\/\/doi.org\/10.1021\/cr0406559","journal-title":"Chem Rev"},{"issue":"1","key":"445_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/cr010210+","volume":"103","author":"TG Chasteen","year":"2003","unstructured":"Chasteen TG, Bentley R (2003) Biomethylation of selenium and tellurium: microorganisms and plants. Chem Rev 103(1):1\u201326. https:\/\/doi.org\/10.1021\/cr010210+","journal-title":"Chem Rev"},{"issue":"7","key":"445_CR31","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.fct.2008.04.010","volume":"46","author":"T Abondanza","year":"2008","unstructured":"Abondanza T, Oliveira C, Barbosa C, Pereira F, Cunha RLOR, Caires A, Comasseto JV, Queiroz ML, Valadares MC, Bincoletto C (2008) Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium (IV) compound RT-04. Food Chem Toxicol 46(7):2540\u20132545. https:\/\/doi.org\/10.1016\/j.fct.2008.04.010","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"445_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2007.12.007","volume":"50","author":"D Sredni-Kenigsbuch","year":"2008","unstructured":"Sredni-Kenigsbuch D, Shohat M, Shohat B, Ben-Amitai D, Chan C-C, David M (2008) The novel tellurium immunomodulator AS101 inhibits interleukin-10 production and p38 MAPK expression in atopic dermatitis. J Dermatol Sci 50(3):232\u2013235. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.12.007","journal-title":"J Dermatol Sci"},{"issue":"3","key":"445_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bmcl.2004.11.012","volume":"15","author":"RL Cunha","year":"2005","unstructured":"Cunha RL, Urano ME, Chagas JR, Almeida PC, Bincoletto C, Tersariol IL, Comasseto JV (2005) Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium (IV) compounds as inhibitors of human cathepsin B. Bioorg Med Chem Lett 15(3):755\u2013760. https:\/\/doi.org\/10.1016\/j.bmcl.2004.11.012","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"445_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1049\/iet-nbt.2018.5137","volume":"12","author":"M Shakibaie","year":"2018","unstructured":"Shakibaie M, Abharian A, Forootanfar H, Ameri A, Jafari M, Rahimi HR (2018) Cytotoxicity investigations of biogenic tellurium nanorods towards PC12 cell line. IET Nanobiotechnol 12(8):1144\u20131149. https:\/\/doi.org\/10.1049\/iet-nbt.2018.5137","journal-title":"IET Nanobiotechnol"},{"issue":"3","key":"445_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3347\/kjp.2009.47.3.213","volume":"47","author":"CBC Lima","year":"2009","unstructured":"Lima CBC, Arrais-Silva WW, Cunha RLOR, Giorgio S (2009) A novel organotellurium compound (RT-01) as a new antileishmanial agent. Korean J Parasitol 47(3):213. https:\/\/doi.org\/10.3347\/kjp.2009.47.3.213","journal-title":"Korean J Parasitol"},{"issue":"11","key":"445_CR36","doi-asserted-by":"publisher","first-page":"e48780","DOI":"10.1371\/journal.pone.0048780","volume":"7","author":"IAS Pimentel","year":"2012","unstructured":"Pimentel IAS, de Siqueira PC, Katz S, de Souza J\u00fadice WA, Cunha RL, Barbieri CL (2012) In vitro and in vivo activity of an organic tellurium compound on Leishmania (Leishmania) chagasi. PLoS ONE 7(11):e48780. https:\/\/doi.org\/10.1371\/journal.pone.0048780","journal-title":"PLoS ONE"},{"issue":"2","key":"445_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jtcme.2014.11.004","volume":"5","author":"A Dalimi","year":"2015","unstructured":"Dalimi A, Delavari M, Ghaffarifar F, Sadraei J (2015) In vitro and in vivo antileishmanial effects of aloe-emodin on Leishmania major. J Tradit Complement Med 5(2):96\u201399. https:\/\/doi.org\/10.1016\/j.jtcme.2014.11.004","journal-title":"J Tradit Complement Med"},{"issue":"11","key":"445_CR38","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s10953-014-0260-6","volume":"43","author":"QA Bhatti","year":"2014","unstructured":"Bhatti QA, Baloch MK, Schwarz S, Petzold G (2014) Effect of various parameters on the stability of silica dispersions. J Solut Chem 43(11):1916\u20131928. https:\/\/doi.org\/10.1007\/s10953-014-0260-6","journal-title":"J Solut Chem"},{"issue":"22","key":"445_CR39","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.matlet.2009.06.018","volume":"63","author":"B Qin","year":"2009","unstructured":"Qin B, Bai Y, Zhou Y, Liu J, Xie X, Zheng W (2009) Structure and characterization of TeO2 nanoparticles prepared in acid medium. Mater Lett 63(22):1949\u20131951. https:\/\/doi.org\/10.1016\/j.matlet.2009.06.018","journal-title":"Mater Lett"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-021-00445-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-021-00445-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-021-00445-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T11:38:22Z","timestamp":1647862702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-021-00445-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1007\/s11686-021-00445-w","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"4 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by ethical committee of Tarbiat Modares University with number IRMODARES.REC 1397-177; 5-Jan-2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}